Transcriptome sequencing and bioinformatics analyses show that TMEM43 mutations may lead to hearing loss by affecting the PI3K-Akt signaling pathway and calcium signaling pathway resulting in decreased gap junction function, which may provide new ideas for drug screening and gene therapy. Here, AKT1 is linked to hearing loss disorder.